The FDA has approved the first and so far only pharmacological treatment for presbyopia, a sight condition that typically starts in middle age and involves difficulty in focusing on near objects ...
Mumbai-based Entod Pharmaceuticals has developed PresVu Eye Drops for presbyopia treatment, a condition which affects between 1.09 billion and 1.80 billion people worldwide. Presbyopia occurs ...
LENZ Therapeutics (formerly Presbyopia Therapies) is working on eyedrops containing aceclidine – thought to act like pilocarpine as a miotic agent, reducing eye pressure – showed improvements ...
Last week, controversy over the claims over the prowess of eye drops prescribed for presbyopia (progressive loss of the near focusing ability of the eye due to ageing), led to the Central Drugs ...
The Drugs Controller General of India has approved Entod Pharmaceuticals' PresVu eye drops, which is said to be a breakthrough in the treatment of presbyopia. The pharmaceutical company has ...
But through all of this, there has been renewed interest in presbyopia — what is it, and whom does it affect? Presbyopia, states the Mayo Clinic’s website, is the gradual loss of your eyes ...
A Place In The Sun presenter Jean Johannsson has been diagnosed with presbyopia - the gradual loss of your eyes' ability to focus on nearby objects. After being in denial about her declining ...
The Drug Controller General of India, India's drug regulatory authority, has approved a novel treatment aimed at relieving millions of people with presbyopia—a common age-related vision ...
Entod Pharmaceuticals has unveiled PresVu, India's first eye drop developed to lessen dependence on reading glasses for those with presbyopia. Affecting people over 40, this condition hampers the ...
This condition, called presbyopia, affects near vision and often requires reading glasses. It typically starts in the middle age. "PresVu is essentially a lower-concentration pilocarpine ...
Developed by Mumbai-based Entod Pharmaceuticals, PresVu eye drops have been developed for presbyopia, an age-related vision condition that typically affects those above 40, causing difficulty ...